We are only weeks away from November and Mississippi voters will be able to vote on a pair of dueling medical marijuana initiatives.
The state’s Governor Tate Reeves (R) has signed legislation that amends state law to allow people to obtain marijuana-derived medications that are approved by the Food and Drug Administration (FDA).
Reeves is against broader medical cannabis reform and stated that he’s “against efforts to make marijuana mainstream.”
“That said—helping people with safe treatments should not be off the table,” he said.
He tweeted, “I’m against efforts to make marijuana mainstream. That said—helping people with safe treatments should not be off the table. Just signed a bill for kids like Brady and Brianna with a rare form of epilepsy to get FDA-approved treatment. @SenatorHarkins led on it for years!
Reeves’s tweet about signing the legislation included photos of him with those children.
The bill Reeves signs means that federally approved cannabis medications would be removed from Schedule V of Mississippi’s drug code. It was six months ago that the Drug Enforcement Administration removed the CBD-derived medication Epidiolex from the federal Controlled Substances Act.
“I am so glad that this bill may help Brady and Brianna, but Initiative 65 for medical marijuana will help thousands of families across the state with loved ones suffering from 22 debilitating medical conditions including cancer, seizures, PTSD, chronic pain, multiple sclerosis and ALS,” Jamie Grantham, communications director for Mississippians for Compassionate Care (MCC), told Marijuana Moment. “I encourage voters to vote YES for Initiative 65 on November 3!”